Institutional members access full text with Ovid®

Share this article on:

The Risk of Knee Arthroplasty Following Cruciate Ligament Reconstruction: A Population-Based Matched Cohort Study

Leroux, Timothy MD, MEd; Ogilvie-Harris, Darrell MBBS, FRCSC; Dwyer, Tim MD, FRCSC, FRACS; Chahal, Jaskarndip MD, MSc, FRCSC; Gandhi, Rajiv MD, MSc, FRCSC; Mahomed, Nizar MD, ScD, FRCSC; Wasserstein, David MD, MSc, FRCSC

Journal of Bone & Joint Surgery - American Volume: 1 January 2014 - Volume 96 - Issue 1 - p 2–10
doi: 10.2106/JBJS.M.00393
Scientific Articles
Disclosures

Background: Evidence regarding the risk of end-stage osteoarthritis following cruciate ligament reconstruction is based upon small sample sizes and radiographic, rather than clinical, criteria. The goals of this study were to determine the risk of knee arthroplasty, a surrogate for end-stage osteoarthritis, following cruciate ligament reconstruction, and to identify patient, provider, and surgical factors that influence knee arthroplasty risk.

Methods: Using administrative databases, we identified all patients who were sixteen to sixty years of age and had undergone cruciate ligament reconstruction in Ontario from July 1993 to March 2008. Case patients were matched by demographic variables to five individuals without knee injury from the general population of Ontario, Canada, who had not undergone previous knee surgery, including cruciate ligament reconstruction. The main outcome was knee arthroplasty. Kaplan-Meier survival curves were generated for both cohorts. A Cox proportional hazards model determined those factors that influenced knee arthroplasty risk.

Results: We identified 30,301 eligible patients who had undergone cruciate ligament reconstruction; of these patients, 30,277 were matched to 151,362 individuals from the general population; the median patient age was twenty-eight years and 65% of the patients were male. Primary anterior cruciate ligament reconstruction accounted for >98% of index cases. During the follow-up period, there was a significant difference (p < 0.001) between matched case and control cohorts with respect to the number of patients who underwent knee arthroplasty during the study period; in the matched case cohort, 209 patients underwent knee arthroplasty (event rate, 0.68 of 1000 person-years), and in the control cohort, 125 patients underwent knee arthroplasty (event rate, 0.10 of 1000 person-years). Moreover, fifteen years after cruciate ligament reconstruction (case cohort) or study enrollment (control cohort), there was a significant difference (p < 0.001) in the cumulative incidence of knee arthroplasty between the case cohort (1.4%) and the control cohort (0.2%). Age of fifty years or more (hazard ratio, 37.28; p < 0.001), female sex (hazard ratio, 1.58; p = 0.001), comorbidity score of ≥5 points (hazard ratio, 5.91; p = 0.002), surgeon annual volume of cruciate ligament reconstruction of twelve or fewer cases per year (hazard ratio, 2.53; p < 0.001), and cruciate ligament reconstruction undertaken in university-affiliated hospitals (hazard ratio, 1.51, p = 0.008) increased the odds of knee arthroplasty; however, male sex (hazard ratio, 0.63; p = 0.001) and patient age of less than twenty years (hazard ratio, 0.07; p = 0.009) were protective. Concurrent meniscal repair or debridement did not increase arthroscopy risk.

Conclusions: After fifteen years, the cumulative incidence of knee arthroplasty following cruciate ligament reconstruction was low (1.4%); however, it was seven times greater than the cumulative incidence of knee arthroplasty among matched control patients from the general population (0.2%). Older age, female sex, higher comorbidity, low surgeon annual volume of cruciate ligament reconstruction, and cruciate ligament reconstruction performed in a university-affiliated hospital were factors that increased knee arthroplasty risk.

Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

1University of Toronto Orthopaedic Sports Medicine, 149 College Street, Room 508-A, Toronto, ON M5T 1P5, Canada. E-mail address for T. Leroux: timothy.leroux@mail.utoronto.ca

2Arthritis Research Unit, Toronto Western Hospital (University Health Network), 399 Bathurst Street, Suite 1E-435, Toronto, ON M5T 2S8, Canada

3Sunnybrook Health Sciences Center, 2075 Bayview Avenue, Room MG 301, Toronto, ON M4Y 1H1, Canada. E-mail address: david.wasserstein@mail.utoronto.ca

Copyright 2014 by The Journal of Bone and Joint Surgery, Incorporated
You currently do not have access to this article

To access this article: